Loading company
Kestra Medical Technologies, Ltd.
KMTS · Nasdaq · Healthcare · Medical Instruments and Supplies
$28.44+1.1%Sep 29 close
- 1M
- +10.9%
- 6M
- +55.2%
- 1Y
- +19.7%
KMTS · Nasdaq · Healthcare · Medical Instruments and Supplies
$28.44+1.1%Sep 29 close
The quarter ending July 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toJul 31, 2026 | 3 months toJul 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $31M | $19.4M | +59.88% |
| Profit | -$44.1M | -$25.8M | -70.71% |
| Profit per share | -$0.75 | -$0.50 | -50.00% |
| Free Cash Flow | -$40.6M | -$34.4M | -17.97% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
A short summary of each call — what the quarter showed, what management expects and whether they delivered on what they said last time — with the full transcript underneath.
“Kestra delivered another strong quarter of financial performance, generating revenue growth of 60% while expanding gross margin to over 56%,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Kestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Kestra Medical Technologies, Ltd.’s Item 2.02 8-K filed September 14, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Source: Yahoo Finance, transcribed by Quartr. Speaker names and roles are as transcribed; analysts are sometimes unnamed.
Call summaries are part of Pro
A two-minute read of every Kestra Medical Technologies, Ltd. earnings call: the numbers that mattered, what management expects, whether they delivered on last quarter’s outlook, and what analysts asked that went unanswered.
See one first on , , or — open to everyone.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.